Discover Tenders by Drugs Cancer Oncology Sector

Find the most relevant tenders for Drugs Cancer Oncology. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Drugs Cancer Oncology tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Drugs Cancer Oncology tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Brinzolamide Brimonidine Atc S01Ec24 For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7238843

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Open House Drug Discount Agreements Botulinum Toxin Type A Finished Medicinal Product Name Botox R Atc M03Ax21

Deadline: 05 Jul 2026

Germany

Ref. No.: 7224030

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Open House Drug Rebate Agreements Dexamethasone As Intravitreal Implant Atc S01Ba01

Deadline: 05 Jul 2026

Germany

Ref. No.: 7223267

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Open House Drug Rebate Agreements Emtricitabine Tenofovir Disoproxil And Rilpivirine Atc J05Ar08

Deadline: 05 Jul 2026

Germany

Ref. No.: 7217553

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Triptorelin Atc L02Ae04 Obo For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7200637

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Fingolimod Atc Code According To Who L04Ae01

Deadline: 30 Sep 2026

Germany

Ref. No.: 7197234

EMD:Ref Document

Bid Value: Ref Document

296 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Abatacept Atc L04Aa24 Obo For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7196201

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Lidocaine Atc N01Bb02 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7195634

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Ranibizumab Atc S01La04 Obo For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7192749

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Naproxen Excluding The Syrup Dosage Form Atc Code According To Who M01Ae

Deadline: 31 Aug 2026

Germany

Ref. No.: 7191964

EMD:Ref Document

Bid Value: Ref Document

266 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Tacrolimus Atc L04Ad02 Obo For The Period 01 09 2024 31 08 2025 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2026

Germany

Ref. No.: 7191811

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Olopatadine Atc S01Gx09 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7190250

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Febuxostat Atc Code According To Who M04Aa03

Deadline: 30 Sep 2026

Germany

Ref. No.: 7189556

EMD:Ref Document

Bid Value: Ref Document

296 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Chlorthalidone Atc C03Ba04 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7189539

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Capsaicin Atc N01Bx04 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7186844

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Showing 33526 to 33540 of 33742 results

‹
1
2
...
2233
2234
2235
2236
2237
2238
2239
...
2249
2250
›

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

FREE Trial plan for all new users!